Neurodegenerative diseases such as Alzheimer’s, Parkinson’s and Huntington’s disease and amyotrophic lateral sclerosis (ALS) for the most part lack truly effective disease-modifying therapies.

Immunotherapy aims to enhance the body's immune system to recognize and attack cancer cells. Types of immunotherapy used to treat stage 4 lymphoma include: CAR T-Cell Therapy This is a type of ...

If this happens it will opens up the possibility for an effective restorative treatment for Parkinson’s patients. Reference: Clinical application of stem cell therapy in Parkinson's disease ...

Bayer subsidiary BlueRock Therapeutics has been granted a fast-track review by the FDA for DA01, its stem cell-based therapy for Parkinson's disease which is currently in early-stage clinical testing.

Current treatments for Parkinson’s ... stem cells (iPSCs) into the brains of rhesus monkeys modeling PD not only improved motor function and neuron growth over a two-year period, but also boosted the ...

DIABETES, Parkinson's disease, degenerative disc disease, macular degeneration, stroke — what do these have in common? Besides being relatively debilitating conditions, all of these have been treated ...

There has been some controversy surrounding stem cell research over the years, as embryonic stem cells are taken from early-stage human ... stem cell therapy for Parkinson’s, but clinical ...

In the BlueRock trial, an unnamed patient has now been administered the first dose of pluripotent stem cell ... and late-stage Parkinson's will receive a single dose of the gene therapy, and ...